CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 14.59: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.87%
Annual Rate
CNY 0.54Paid semi-annual
Payout Ratio
39.7%Sustainable
Last Ex-Dividend
May 21, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.53BCNY974.04M · vs all stocks (USD)
Trailing P/E
59.25xRevenue (TTM)
711.19MCNY106.12M · vs all stocks (USD)
Profit Margin
15.40%Beta
0.6420xvs all stocks
52-Week Change
10.88%vs all stocks
Forward Annual Dividend Yield
0.87%vs all stocks
Market Capitalization
6.53BCNY974.04M · vs all stocks (USD)
Enterprise Value
5.35BCNY797.65M · vs all stocks (USD)
Trailing P/E
59.25xForward P/E
33.13xPrice to Sales (TTM)
9.18xPrice to Book (MRQ)
2.70xEnterprise to Revenue
7.52xEnterprise to EBITDA
34.95xGross Margin
35.34%Profit Margin
15.40%Operating Margin
18.94%Return on Assets (TTM)
2.57%Return on Equity (TTM)
4.42%Revenue (TTM)
711.19MCNY106.12M · vs all stocks (USD)
Revenue per Share (TTM)
6.63CNYUpdated Sep 21, 2026Quarterly Revenue Growth
53.50%Gross Profit (TTM)
228.71MCNY34.13M · vs all stocks (USD)
EBITDA (TTM)
129.67MCNY19.35M · vs all stocks (USD)
Net Income (TTM)
109.51MCNY16.34M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-9.20%Operating Cash Flow (TTM)
159.52MCNY23.80M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-183.18MCNY-27.33M · vs all stocks (USD)
Forward Annual Dividend Rate
0.5400CNYUpdated Sep 21, 2026Forward Annual Dividend Yield
0.87%vs all stocks
Trailing Annual Dividend Rate
0.4050CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
0.65%vs all stocks
Payout Ratio
39.73%Minority Interest (Equity)
6.33MCNYFY2025 · Dec 31, 2025Revenue
602.26MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
392.51MCNYFY2025 · Dec 31, 2025Gross Profit
209.75MCNYFY2025 · Dec 31, 2025Operating Income
116.64MCNY17.40M · vs all stocks (USD)
Pre-tax Income
129.27MCNYFY2025 · Dec 31, 2025Income Tax Expense
18.43MCNYFY2025 · Dec 31, 2025Net Income
110.84MCNYFY2025 · Dec 31, 2025EBIT
129.97MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
165.77MCNYFY2025 · Dec 31, 2025Research & Development
40.93MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
15.14MCNYFY2025 · Dec 31, 2025Other Operating Expenses
6.60MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
16.47MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
698.04KCNYFY2025 · Dec 31, 2025EPS (Basic)
1.07CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.07CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
107.20MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
107.20MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
110.84MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
3.81MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
248.46MCNYFY2025 · Dec 31, 2025Free Cash Flow
37.99MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
406.48MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
110.84MCNYFY2025 · Dec 31, 2025Other Non-cash Items
8.40MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
146.15MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-16.93MCNYFY2025 · Dec 31, 2025Capital Expenditures
-210.47MCNYFY2025 · Dec 31, 2025Net Acquisitions
-55.60MCNYFY2025 · Dec 31, 2025Purchase of Investments
-5.38BCNYFY2025 · Dec 31, 2025Sale of Investments
5.72BCNYFY2025 · Dec 31, 2025Other Investing Activity
16.76MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
96.76MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
114.47MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-195.99MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-43.44MCNYFY2025 · Dec 31, 2025Other Financing Charges
2.65MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-122.31MCNYFY2025 · Dec 31, 2025Shares Outstanding
108.00MSharesUpdated Sep 21, 2026Float Shares
40.37MSharesUpdated Sep 21, 2026% Held by Insiders
68.85%vs all stocks
% Held by Institutions
7.45%vs all stocks
Total Cash (MRQ)
1.26BCNY187.62M · vs all stocks (USD)
Total Cash per Share (MRQ)
11.73CNYUpdated Sep 21, 2026Total Debt (MRQ)
119.67MCNY17.86M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0498xCurrent Ratio (MRQ)
4.91xBook Value per Share (MRQ)
22.40CNYUpdated Sep 21, 2026Total Assets
2.65BCNY396.09M · vs all stocks (USD)
Total Current Assets
1.69BCNYFY2025 · Dec 31, 2025Total Liabilities
295.24MCNYFY2025 · Dec 31, 2025Total Non-current Assets
964.41MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
56.37MCNYFY2025 · Dec 31, 2025Total Current Liabilities
238.87MCNYFY2025 · Dec 31, 2025Cash
406.48MCNYFY2025 · Dec 31, 2025Cash Equivalents
2.18MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
408.66MCNYFY2025 · Dec 31, 2025Other Short-term Investments
902.02MCNYFY2025 · Dec 31, 2025Accounts Receivable
158.37MCNYFY2025 · Dec 31, 2025Inventory
161.18MCNYFY2025 · Dec 31, 2025Accounts Payable
152.31MCNYFY2025 · Dec 31, 2025Short-term Debt
11.42MCNYFY2025 · Dec 31, 2025Other Current Liabilities
22.73MCNYFY2025 · Dec 31, 2025Long-term Debt
39.91MCNYFY2025 · Dec 31, 2025Common Stock (Book)
108.00MCNYFY2025 · Dec 31, 2025Retained Earnings
529.39MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.36BCNY352.04M · vs all stocks (USD)
Treasury Stock
33.42MCNYFY2025 · Dec 31, 202552-Week Low
46.69CNYUpdated Sep 21, 202652-Week High
74.68CNYUpdated Sep 21, 202652-Week Change
10.88%vs all stocks
Beta
0.6420xvs all stocks
50-Day MA
60.69CNYUpdated Sep 21, 2026200-Day MA
56.12CNYUpdated Sep 21, 2026Avg 10-Day Volume
2.71MSharesUpdated Sep 21, 2026Avg 30-Day Volume
2.83MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
1.02CNYUpdated Sep 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Cash Backing With OCF Coverage And Cash Near Total Debt
Cash on hand covers most or all of its total debt, and cash flow matches reported earnings.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 14.59: safe zoneNotable
Altman Z-Score: 14.59
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Frontier Biotechnologies Inc.
Tier 1ProductionApproval-Gated PipelineRule
Corvus Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Procept BioRobotics Corporation
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Ausun Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Wuhan Huakang Century Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jinghua Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Hangzhou Biotest Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Arbutus Biopharma Corporation
Tier 1ProductionApproval-Gated PipelineRuleRisk
Cisen Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Edan Instruments Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Zhenjiang Dongfang Electric Co., Ltd.
1 interpretationCash Backing With OCF Coverage And Cash Near Total Debt
Lingda Group Co., Ltd.
1 interpretationCash Backing With OCF Coverage And Cash Near Total Debt
Suzhou Electrical Apparatus Science Academy Co. Ltd.
1 interpretationCash Backing With OCF Coverage And Cash Near Total Debt